DNLI · Categories · Form 5

DNLI - SEC Form 5 annual insider statements

Denali Therapeutics Inc. (DNLI) sec form 5 annual insider statements - real-time wire coverage filtered to Form 5 only.

Recent Form 5 for DNLI

• 1572d
  SEC Form 5: Tessier-Lavigne Marc decreased direct ownership by 9% to 2,044,370 units

  5 - Denali Therapeutics Inc. (0001714899) (Issuer)

Other DNLI categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 3
• DEF 14A
• M&A
• Earnings
• Dividends